<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941205-0-00063</title>
	</head>
	<body>
		<main>
			<p><!-- PJG ITAG l=10 g=1 f=2 --> EFFECTIVE DATE: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  December 5, 1994. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> <!-- PJG STAG 4700 -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=52 g=1 f=1 -->  <CFRNO>21 CFR Part 558</CFRNO> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 -->  <DOCTITLE>New Animal Drugs for Use in Animal Feeds; Monensin and Bacitracin Methylene Disalicylate</DOCTITLE> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <AGENCY> <!-- PJG ITAG l=10 g=1 f=2 --> AGENCY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Food and Drug Administration, HHS.  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </AGENCY> <ACTION> <!-- PJG ITAG l=10 g=1 f=2 --> ACTION: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Final rule. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=59 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </ACTION> <SUMMARY> <!-- PJG ITAG l=10 g=1 f=2 --> SUMMARY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Elanco Animal Health, Division of Eli Lily and Co. The NADA provides for use of two separately approved Type A medicated articles, one containing monensin sodium and the other containing bacitracin methylene disalicylate, to make combination Type C medicated feeds for the prevention of coccidiosis, for increased rate of weight gain and for improved feed efficiency in growing turkeys. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </SUMMARY> <DATE> <!-- PJG ITAG l=10 g=1 f=2 --> EFFECTIVE DATE: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  December 5, 1994. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </DATE> <FURTHER> <!-- PJG ITAG l=10 g=1 f=2 --> FOR FURTHER INFORMATION CONTACT: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  James F. McCormack, Center for Veterinary Medicine (HFV&hyph;128), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301&hyph;594&hyph;1602. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </FURTHER> <SUPPLEM> <!-- PJG ITAG l=10 g=1 f=2 --> SUPPLEMENTARY INFORMATION: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Elanco Animal Health, Division of Eli Lilly and Co., Lilly Corporate Center, Indianapolis, IN 46285, has filed NADA 140&hyph;937. The NADA provides for use of separately approved 45 and 60 grams per pound (g/lb) monensin and 10, 25, 30, 40, 50, and 60 g/lb bacitracin methylene disalicylate Type A medicated articles to make Type C medicated feeds containing 54 to 90 g per ton (g/t) monensin and 4 to 50 g/t bacitracin methylene disalicylate. The feed is used for the prevention of coccidiosis caused by  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=3 --> Eimeria adenoeides <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> ,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=3 --> E <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=3 --> meleagrimitis <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> , and  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=3 --> E <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=3 --> gallopavonis <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> , for increased rate of weight gain, and for improved feed efficiency in growing turkeys. The NADA is approved as of November 8, 1994, and the regulations are amended in 21 CFR 558.355(f)(2) to reflect the approval. The basis for approval is discussed in the freedom of information summary. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Certain limitations currently required on the monensin turkey feed labeling are not in the regulations. At this time, FDA is adding these limitations to the regulations. <!-- PJG 0012 frnewline --> In accordance with the freedom of information provisions of 21 CFR part 20 and 21 CFR 514.11(e)(2)(ii), a summary of safety and effectiveness data and information submitted to support approval of this application may be seen in the Dockets Management Branch (HFA&hyph;305), Food and Drug Administration, rm. 1&hyph;23, 12420 Parklawn Dr., Rockville, MD 20857, from 9 a.m. to 4 p.m., Monday through Friday. <!-- PJG 0012 frnewline --> Under section 512(c)(2)(F)(ii) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b(c)(2)(F)(ii)), this approval qualifies for 3 years of marketing exclusivity beginning November 8, 1994, because the application contains reports of new clinical or field investigations (other than bioequivalence or residue studies) or human food safety studies (other than bioequivalence or residue studies) essential to the approval and conducted or sponsored by the applicant. <!-- PJG 0012 frnewline --> The agency has determined under 21 CFR 25.24(d)(1)(ii) that this action is of a type that does not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment nor an environmental impact statement is required. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> List of Subjects in 21 CFR Part 558  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Animal drugs, Animal feeds. <!-- PJG 0012 frnewline --> Therefore, under the Federal Food, Drug, and Cosmetic Act and under the authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 558 is amended as follows: <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=52 g=1 f=1 --> PART 558_NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 1. The authority citation for 21 CFR part 558 continues to read as follows: <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=4 --> Authority: <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  Secs. 512, 701 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b, 371). <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> 2. Section 558.355 is amended by redesignating paragraphs (f)(2)(ii) and (f)(2)(iii) as paragraphs (f)(2)(i)( <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> a <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ) and (f)(2)(i)( <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> b <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ), respectively, by revising newly redesignated paragraph (f)(2)(i)( <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> b <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ), and by adding new paragraph (f)(2)(ii) to read as follows: <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;558.355  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Monensin. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * * <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (f) * * * <!-- PJG 0012 frnewline --> (2) * * * <!-- PJG 0012 frnewline --> (i) * * * <!-- PJG 0012 frnewline --> ( <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> b <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> )  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Limitations <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> . For growing turkeys only; as monensin sodium; feed continuously as sole ration. Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal. Some strains of turkey coccidia may be monensin tolerant or resistant. Monensin may interfere with development of immunity to turkey coccidiosis. <!-- PJG 0012 frnewline --> (ii)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Amount per ton <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> . Monensin, 54 to 90 grams, and bacitracin methylene disalicylate, 4 to 50 grams. <!-- PJG 0012 frnewline --> ( <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> a <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> )  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Indications for use <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> . For prevention of coccidiosis caused by  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Eimeria <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> adenoeides <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> E <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> meleagrimitis <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> , and  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> E <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> gallopavonis <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> , for increased rate of weight gain, and for improved feed efficiency. <!-- PJG 0012 frnewline --> ( <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> b <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> )  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Limitations <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> . For growing turkeys only; as monensin sodium; feed continuously as sole ration. Do not allow horses, other equines, mature turkeys or guinea fowl access to feed containing monensin. Ingestion of monensin by horses and guinea fowl has been fatal. Some strains of turkey coccidia may be monensin tolerant or resistant. Monensin may interfere with development of immunity to turkey coccidiosis. Bacitracin methylene disalicylate as provided by No. 046573 in &sect;510.600(c) of this chapter. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 -->  * * * * * <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: November 18, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SUPPLEM> <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Richard H. Teske, <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Deputy Director, Pre-market Review, Center for Veterinary Medicine. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;29855 Filed 12&hyph;2&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4160&hyph;01&hyph;F <!-- PJG /ITAG --> </BILLING>  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            